Zevra Therapeutics, Inc. (ZVRA) SEC Filings — 2025
15 SEC filings for Zevra Therapeutics, Inc. (ZVRA) in 2025.
Filings
- Zevra Therapeutics Announces Board and Executive Changes — 8-K · Dec 17, 2025
- Zevra Therapeutics, Inc. 8-K Filing — 8-K · Dec 2, 2025
- Zevra Therapeutics Files 8-K on Governance and Compensation — 8-K · Nov 20, 2025
- Zevra Swings to Profit on PRV Sale, Revenue Jumps — 10-Q · Nov 5, 2025
- Zevra's Q2 Losses Widen Amidst R&D Spend — 10-Q · Aug 12, 2025
- Zevra Therapeutics Files 8-K on Security Holder Vote — 8-K · May 29, 2025
- Zevra Therapeutics Files Proxy Materials — DEFA14A · May 21, 2025
- Zevra Therapeutics Q1 2025: Minimal Revenue, Significant Net Loss — 10-Q · May 13, 2025
- Zevra Therapeutics Files Proxy Materials — DEFA14A · May 8, 2025
- Zevra Therapeutics Files Proxy Materials — DEFA14A · Apr 21, 2025
- Zevra Therapeutics Files 8-K on Asset Disposition & Financials — 8-K · Apr 7, 2025
- Zevra Therapeutics Files Proxy Statement — DEFA14A · Mar 31, 2025
- Zevra Therapeutics Files 2024 10-K — 10-K · Mar 12, 2025
- Zevra Therapeutics Files 8-K on Financials — 8-K · Mar 11, 2025
- Zevra Therapeutics Files 8-K with Material Agreement — 8-K · Feb 27, 2025